Detalhe da pesquisa
1.
Efficacy and safety of idecabtagene vicleucel in patients with relapsed-refractory multiple myeloma not meeting the KarMMa-1 trial eligibility criteria: A real-world multicentre study.
Br J Haematol
; 204(4): 1293-1299, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38263627
2.
Safety and efficacy of eltrombopag in patients with post-CAR T cytopenias.
Eur J Haematol
; 112(4): 538-546, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38044594
3.
Efficacy and safety of daratumumab, pomalidomide, and dexamethasone versus daratumumab, carfilzomib, and dexamethasone in daratumumab-naïve relapsed multiple myeloma.
Eur J Haematol
; 112(6): 975-983, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38382632